Tempus ECG-Low EF vs eMurmur Heart AI

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Tempus ECG-Low EF
by Tempus
VS
eMurmur Heart AI
by eMurmur

AI Verdict

Tempus ECG-Low EF analyzes 12-lead ECG recordings to detect signs of low left ventricular ejection fraction, aiding in heart failure risk assessment. In contrast, eMurmur Heart AI processes heart and lung sounds from auscultation to detect murmurs and provide hemodynamic insights. While both are FDA-cleared AI tools for cardiac assessment, they utilize distinct data modalities and focus on different diagnostic aspects, making them complementary rather than direct competitors.

Choose Tempus ECG-Low EF if…

Choose Tempus ECG-Low EF if your primary objective is to leverage existing 12-lead ECG data for the early identification of patients 40 years or older who may be at risk for heart failure due to low left ventricular ejection fraction (LVEF ≤40%). This tool is best suited for integration into clinical diagnostic workflows within healthcare facilities to provide a binary output that aids clinicians in determining the need for further cardiac evaluation.

View Tempus ECG-Low EF →

Choose eMurmur Heart AI if…

Choose eMurmur Heart AI if you require an AI-powered platform for automated analysis of heart and lung sounds, focusing on the detection and classification of murmurs and providing hemodynamic insights. This solution is ideal for telehealth, remote monitoring, and screening in diverse healthcare settings, enabling live streaming, secure storage, and longitudinal comparison of auscultation data.

View eMurmur Heart AI →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Tempus ECG-Low EF eMurmur Heart AI
Pricing Unknown Contact for quote
Deployment Integrates with current ECG platforms and electronic health records (EHRs). Web-based, Mobile App, API integration
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

eMurmur Heart AI

Tool B (eMurmur Heart AI) offers a wider range of deployment options, including cloud-based, web application, and mobile app, supporting telehealth and remote auscultation. This provides greater flexibility and accessibility across various clinical settings compared to Tool A's (Tempus ECG-Low EF) more integrated, but potentially less versatile, workflow.

Clinical Value

Tempus ECG-Low EF

While both are FDA-cleared and clinically valuable, Tool A (Tempus ECG-Low EF) provides a direct and actionable binary output for a critical and often underdiagnosed condition (low LVEF) from a standard ECG. This specific, high-impact insight into heart failure risk offers a more immediate and targeted clinical value compared to Tool B's broader auscultation analysis of heart and lung sounds.

Pricing & Value

Tie

Both tools lack transparent pricing information, requiring direct contact with the vendor for details. Without specific cost structures or further information on their respective value propositions, it is impossible to conduct a meaningful comparison of their pricing and overall value.

Enterprise Readiness

Tempus ECG-Low EF

Both tools are FDA-cleared, HIPAA compliant, and offer BAAs. However, Tempus (Tool A) provides more extensive details and examples of its deep and widespread EHR integrations with major systems like Epic and Cerner, and its focus on embedding AI insights directly into existing clinical workflows.

Innovation

eMurmur Heart AI

Tool B (eMurmur Heart AI) demonstrates broader innovation by transforming traditional auscultation through AI, integrating it with telehealth, and offering hardware-agnostic mobile and web access. This approach significantly expands the utility and accessibility of a fundamental diagnostic practice, whereas Tool A focuses on a specific, albeit impactful, AI application to ECG analysis.

Support & Docs

Tempus ECG-Low EF

Tempus (Tool A) explicitly mentions a customer support team with a phone number (800-739-4137) and specific hours of operation (8:00 am CT u2013 5:00 pm CT, Monday through Friday), along with email support. While eMurmur (Tool B) provides an email for general inquiries, it does not detail the scope or availability of its support in the same structured way.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Tempus ECG-Low EF eMurmur Heart AI
Name Tempus ECG-Low EF eMurmur Heart AI
Company Tempus AI CSD Labs
Primary Analysis Input 12-lead ECG recordings Heart and lung sounds
Key Output/Detection Detects signs associated with low Left Ventricular Ejection Fraction (LVEF u226440%) Automated analysis of heart and lung sounds, detecting murmurs and providing hemodynamic insights
Specialties Cardiology, Emergency Medicine, Internal Medicine Cardiology, Internal Medicine, Pulmonology

Videos

Demos, reviews, and walkthroughs featuring Tempus ECG-Low EF and eMurmur Heart AI.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Tempus ECG-Low EF is an FDA-cleared AI software that analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF u226440%) in patients 40 years or older at risk of heart failure. eMurmur Heart AI, conversely, is an FDA-cleared, AI-powered software platform for automated analysis of heart and lung sounds, detecting murmurs and providing hemodynamic insights.
Tempus ECG-Low EF analyzes resting, non-ambulatory 12-lead ECG recordings. eMurmur Heart AI analyzes heart and lung sounds, supporting digital stethoscopes for its data input.
Tempus ECG-Low EF provides a binary output indicating 'Low LVEF Detected' or 'Not Detected' to aid clinicians in further evaluation, but it is not a standalone diagnostic tool. eMurmur Heart AI offers detection and classification of pathologic and innocent heart murmurs, along with hemodynamic insights such as loudness ratios of S1, systole, S2, and diastole.
Both Tempus ECG-Low EF and eMurmur Heart AI are intended for Cardiology and Internal Medicine. eMurmur Heart AI additionally targets Pulmonology due to its lung sound analysis capabilities.
eMurmur Heart AI supports continuous monitoring through comparison of current and previous auscultation data, and facilitates remote consultations via live streaming and remote auscultation. Tempus ECG-Low EF is not intended for patient monitoring and should not be used for repeated testing of the same patient within a 12-month period.
Tempus ECG-Low EF was trained on a large dataset of over 930,000 ECGs from more than 170,000 patients. The specific training data for eMurmur Heart AI is not detailed beyond its capability for automated heart and lung sound analysis.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Tempus ECG-Low EF or eMurmur Heart AI

Backers

Who funded each tool's parent company.

Tempus ECG-Low EF

AI Tool Finder
AI-powered search. Results may not be comprehensive.